Jayanthi is an Advanced Certified SAS Programmer with a Masters in Molecular Science and Nanotechnology from Louisiana Tech University, Louisiana, USA and another Masters in Biotechnology from Bangalore University, India.

In the last three years, she has extensively worked on statistical reporting and analysis for several studies ranging from the therapeutic areas of pain management to cardiovascular diseases. She has programmed for various Phase II, III and IV clinical trials for FDA and EMEA submissions. She has worked with GlaxoSmithKline, India and Alpharma Pharmaceuticals, USA, prior to joining The George Institute in 2011.

Professor Jeffrey Lipman is a career Intensivist, having worked full-time in Intensive Care Units since 1979.  

He received his medical degree (MBBCh) from the University of Witwatersrand, South Africa and has specialist qualifications in anaesthesia (DA, FFA) and intensive care (FFA Crit Care, FCICM). Prior to moving to Australia in 1997 he was Head of ICU at Baragwanath Hospital in Soweto. Currently he is Director of the Intensive Care Services (Royal Brisbane and Womens’ Hospital), Professor and Head of Anaesthesiology and Critical Care, University of Queensland. He also is the Executive Director of the Burns, Trauma, Critical Care Research Centre at this University. He has Adjunct Professorial appointments at Queensland University of Technology, University of Sydney and the University of Witwatersrand.

His research interests include all aspects of infection management in intensive care. He has a special interest in the pharmacokinetics of antibiotics, an area in which he completed his MD through the Chinese University of Hong Kong. 

He has published over 30 book chapters and over 450 peer-reviewed articles including in high impact journals like NEJM, JAMA and Lancet Infectious Diseases. He has supervised over a dozen PhDs, is Section Editor of a number of peer-reviewed journals and reviews for many more. 

He currently holds dozens of peer-reviewed grants including 4 from NHMRC. Over the recent past the accumulated worth of these grants is over $10 million.  

He has been an invited speaker to over 100 Congresses Nationally and Internationally, being a Keynote speaker in many countries around the world.

He has been the recipient of a number of National and International awards for his service to Intensive Care Medicine.

Dr Jessica Gong is an honorary Senior Fellow in the Women’s Health Program at The George Institute for Global Health, UK, in partnership with Imperial College London. She is also a Research Fellow in data science and epidemiology at University College London.

Jessica completed her PhD at The George Institute for Global Health, focusing on understanding the sex differences in dementia and cognitive decline. After the completion of her PhD, Jessica continues her research in characterising the molecular signatures of the exposome, including environmental, social, and biomedical factors, to better understand the mechanisms involved in dementia and brain-related outcomes, using high-dimensional and large-scale datasets. Jessica’s broad research interests include brain health, equity in health data, omics, and causal inference.

Jessica has previously worked as a data consultant for the World Health Organization during the COVID-19 pandemic in the Western Pacific region. Jessica also worked on research projects in brain health, neuroscience, and health equity at various research institutes around the world, including the Karolinska Institutet, Columbia University, World Health Organization Europe, and the University of Melbourne. Jessica has an MSc in public health from the London School of Hygiene and Tropical Medicine and a BSc in neuroscience from the University of Melbourne

John Chalmers has an outstanding record in hypertension research, both fundamental and clinical. His groundbreaking research on the role of the brain in the development of hypertension led to his election to Fellowship of the Australian Academy of Science and helped establish Flinders University as a leading international centre in hypertension and neuroscience research.

His studies on the treatment of high blood pressure for the prevention of heart attack and stroke have changed the way patients are treated throughout the world. His work has been recognised through many awards including the Wellcome Medal, the RT Hall Prize of the Cardiac Society of Australia and New Zealand, The Zanchetti Lifetime Achievement Award of the European Society of Hypertension and the Volhard Medal of the International Society of Hypertension.

He has been President or Chairman of the Australian Society of Medical Research, The Royal Australasian College of Physicians, the National Health and Medical Research Council of Australia, the WHO Expert Committee on Hypertension, the International Society of Hypertension and the Scientific Advisory Board of the World Heart Federation.

Professor Chalmers' contribution to medical science has been acknowledged through the award of many Honorary Doctoral degrees and extensive appointments on national and international boards and advisory committees. He was appointed a Companion in the Order of Australia (AC) in 1991 and an Officer in the National Order of Merit of France in 2010.

John Chalmers remains an active researcher at The George Institute Australia, where he is a principal investigator on many research grants and Chair of steering committees for major studies, mentors young clinical researchers from around the world, and continues to publish and lecture prolifically. 

John joined The George Institute in March 2014 and has since contributed to a variety of academic and business projects in Australia, in China and with George Clinical.  His current work with the Renal and Metabolic Division includes a prospective national cohort study of Dialysis Outcomes in India, and an epidemiological study of chronic kidney disease of unknown origin in Sri Lanka.

In 2015 John convened the Steering Committee and chaired the Judges Panel for the Affordable Dialysis Prize. From 2017-2022 John played a part in the establishment and leadership of Ellen Medical Devices Pty Ltd, a new Australian company founded to build and test a prototype of the winning entry.

John is a Senior Project Officer with the Cardiovascular Division.  He is working on the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study. This study is assessing a multi-faceted, consumer-focussed e-health strategy to assist people to lower their risks of a cardiovascular disease (CVD) event.

John’s career started in science, with a PhD in nuclear physics from the University of Melbourne. This was followed by a number of IT leadership roles in various industries, including insurance, ISP, defense and aerospace and global professional services.

Joyce is the Quality Assurance Manager at The George Institute, responsible for assisting researchers in achieving and maintaining quality research operations through the provision of policies, procedures, risk management processes and training

Joyce joined The George Institute in 2008 as a Project Manager, setting up the Australian Stroke Registry before moving on to managing randomised control and nursing trials, including a genetic study.  Prior to joining The George Institute, she was an accredited assessor, auditing health and community organisations and consulting to organisations preparing for accreditations.

Joygopal heads Resource Mobilisation at The George Institute for Global Health, India. He and his team are collectively working towards expanding partnerships and are exploring new funding opportunities for different programmes with an aim to successfully drive the mission of the organisation.

He brings with him over 39 years of hands on experience of working with corporates and development sector organizations. He has established, led and grown the resource mobilisation operations of many esteemed organisations namely HelpAge India, SOS Children’s Villages, ActionAid, Public Health Foundation of India (PHFI), Centre for Catalyzing Change (C3) and WISH Foundation.

Joygopal is also a novelist and has published 19 books under his belt with two successful forthcoming web series based on his books. He has been featured in the Limca Book of Records and is recognized as the fastest published crime fiction author of India. In 2014, he was mentioned under The Forbes India list of top 100 Celebrity Authors.

Julie Redfern is Deputy Director, Cardiovascular Division at The George Institute for Global Health, an Associate Professor in the Faculty of Medicine at the University of Sydney and a practising Physiotherapist.  

Julie is an advocate for effective secondary prevention of cardiovascular disease and her research interest is focused on improving clinical practice and reduction of risk factors ultimately in people with a range of chronic diseases.  A/Professor Redfern holds a NHMRC Career Development and Heart Foundation Future Leader Fellowship. She was recently selected on the World Heart Federation Emerging Leader Program and concluded a 6 year term on the CSANZ Board and as Chair of the Allied Health Council.

She is currently the Co-Chair of the Clinical and Preventative Cardiology Council of the Cardiac Society of Australia and New Zealand, Co-Chair of the National Secondary Prevention Alliance and part of the team that won the 2016 Australian Google Impact Challenge. Julie’s research aims to improve access to and engagement with secondary prevention strategies with a focus on technology.